MID-VOLUME · HOSP-HEAVY
amikacin Side Effects
amikacin (also sold as Amikin) sits MID-VOLUME #260 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 42.7% mention hospitalization (6,935 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 16,238
- FAERS reports
FDA Adverse Event Reporting System extract for amikacin. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
amikacin: 42.7% mention hospitalization (6,935 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #260 of 524 by FAERS report count.
Mid-book FAERS page for amikacin (Amikin) (16,238 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
COUGH leads 1,620 of 16,238 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,877 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,283 reports, 20.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,103 |
| DYSPNOEA | 277 |
| SEPTIC SHOCK | 266 |
| THERAPY INTERRUPTED | 220 |
| PNEUMONIA | 214 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 203 |
| HOSPITALISATION | 189 |
| COUGH | 188 |
| SEPSIS | 162 |
| RESPIRATORY FAILURE | 157 |
| PYREXIA | 141 |
| CONDITION AGGRAVATED | 113 |
| ASTHENIA | 105 |
| CARDIAC ARREST | 97 |
| DRUG RESISTANCE | 97 |
| THROMBOCYTOPENIA | 95 |
| FATIGUE | 94 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (6,935, 42.7% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| HOSPITALISATION | 1,360 |
| THERAPY INTERRUPTED | 1,038 |
| DYSPNOEA | 821 |
| COUGH | 741 |
| PNEUMONIA | 519 |
| PYREXIA | 423 |
| DEATH | 401 |
| DYSPHONIA | 362 |
| NAUSEA | 348 |
| DIARRHOEA | 334 |
| FATIGUE | 303 |
| PRODUCTIVE COUGH | 277 |
| ASTHENIA | 274 |
| MALAISE | 269 |
| ACUTE KIDNEY INJURY | 264 |
| CONDITION AGGRAVATED | 262 |
| THROMBOCYTOPENIA | 256 |
How to read amikacin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 16,238 voluntary reports linked to amikacin (Amikin), 2004-2025. Death is listed on 3,283 (20.2%). Hospitalization appears on 6,935 (42.7%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 42.7% mention hospitalization (6,935 reports).
Read with amikacin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 16,243 FAERS cases (Δ 5 heavier vs amikacin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 16,231 FAERS cases (Δ 7 lighter vs amikacin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 16,403 FAERS cases (Δ 165 heavier vs amikacin); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 16,062 FAERS cases (Δ 176 lighter vs amikacin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 41.9 pp vs amikacin's DEATH-HEAVY): CASELOAD · HOSP-MID.
amikacin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.